Decentralised trials for hearing and tinnitus therapies: Lessons from the Digital thErapy For Improved tiNnitus carE (DEFINE) randomised controlled trial
Randomised Controlled Trials (RCTs) are the gold standard for evaluating the efficacy of interventions; yet, traditional methods involving multiple recruitment sites often involve significant logistical and financial challenges. The DEFINE trial demonstrates the feasibility of a decentralised approa...
Saved in:
Published in | PloS one Vol. 20; no. 8; p. e0324927 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
14.08.2025
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
ISSN | 1932-6203 1932-6203 |
DOI | 10.1371/journal.pone.0324927 |
Cover
Summary: | Randomised Controlled Trials (RCTs) are the gold standard for evaluating the efficacy of interventions; yet, traditional methods involving multiple recruitment sites often involve significant logistical and financial challenges. The DEFINE trial demonstrates the feasibility of a decentralised approach to RCTs by comparing smartphone-delivered self-guided tinnitus therapy against one-to-one therapist-facilitated treatment for tinnitus. This trial was conducted entirely remotely, leveraging digital technologies for remote recruitment, data collection, and intervention delivery. A total of 210 participants were recruited through social media platforms over a five-month period. Participants were screened and enrolled by a central trial team remotely, who utilised hearing test smartphone applications and electronic consent forms. Baseline and follow-up assessments were conducted using electronic data capture (EDC) platforms, with high retention rates observed at each time point. The trial successfully recruited and retained participants, demonstrating the efficiency and cost-effectiveness of remotely managed trials. Key findings include a high engagement rate from social media ads, with 151,978 impressions leading to 4,997 clicks (3.3%), with a direct advertising spend of £880. 912 individuals self-screened for eligibility online. The median age of participants was 58.3 years, in line with comparable traditionally-recruiting tinnitus studies, with good geographical distribution across the UK. The trial’s adaptability allowed for protocol adjustments, and real-time monitoring of data quality and completeness. The DEFINE trial demonstrates that decentralised RCTs can offer a viable alternative to traditional RCTs for some hearing and tinnitus research, potentially increasing participant diversity and reducing the burden of research on participants, while maintaining rigorous standards of data collection and participant safety. Increasing clinical use of remote audiological assessment, and hearing implant programming provide increasing opportunities for the adoption of entirely remote or hybrid studies in hearing and tinnitus conditions. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: Oto Health Ltd. provided internal funding for this study. JMuz is Chief Scientific Officer for Oto Health Ltd, JS is the Founder’s Associate at Oto Health Ltd, and JS and JMuz have financial interests in Oto Health Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no products in development associated with this research to declare but the Oto app is commercially marketed by Oto Health Ltd. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0324927 |